SCHEMBL366790

SCHEMBL366790

CN(C)C(=O)c1cc(O)c2c(C(=O)O)c3ccccc3n2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.41
SRC P12931 3/20 0.41
AGTR1 P30556 5/20 0.39
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
POLB P06746 1/20 0.39
RARG P13631 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
TP53 P04637 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 1/20 0.36
HIF1A Q16665 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
PMM2 O15305 1/20 0.36
MPI P34949 1/20 0.36
PHOSPHO1 Q8TCT1 1/20 0.36
PGR P06401 1/20 0.35
GAA P10253 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL365789 0.87 EGFR (0.41) EGFRSRCAGTR1KDM4EALDH1A1
SCHEMBL366821 0.87 AGTR1 (0.41) EGFRSRCAGTR1KDM4EALDH1A1
SCHEMBL366034 0.84 ATM (0.41) EGFRSRCAGTR1KDM4EALDH1A1
SCHEMBL367256 0.83 EGFR (0.40) EGFRSRCAGTR1KDM4EALDH1A1
SCHEMBL365213 0.80 PKM (0.39) EGFRSRCALDH1A1MEN1KMT2A
SCHEMBL367205 0.79 EGFR (0.45) EGFRSRCAGTR1KDM4EALDH1A1
SCHEMBL365023 0.78 EGFR (0.40) EGFRSRCAGTR1KDM4EALDH1A1
SCHEMBL367222 0.75 EGFR (0.41) EGFRSRCPOLBCYP3A4TDP1
SCHEMBL366116 0.72 CA1 (0.41) EGFRAGTR1
SCHEMBL365176 0.72 ATM (0.45) KDM4EALDH1A1HPGDPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012007008-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO claimed
WO-2012007008-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO disclosed